Supreme Court ruling on Roundup points to a confusing difference between the law and science

Supreme Court ruled in favor of Monsanto (now Bayer) in a case involving glyphosate-based Roundup herbicide, rejecting claims that its labels must carry cancer warnings under federal law. The decision overturns lower court rulings that had required warnings based on the International Agency for Research on Cancer (IARC) classifying glyphosate as a *probable* carcinogen. The ruling limits the scope of liability for pesticide manufacturers, aligning with EPA and FDA assessments that glyphosate poses no significant cancer risk when used as directed.

Coverage highlights the tension between legal precedent and scientific consensus. Legal analysts, including City Journal, frame the decision as a victory for corporate defendants and a setback for plaintiffs’ lawyers who had pursued mass litigation. SCOTUSblog notes the ruling narrows the interpretation of pesticide labeling laws under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA).

Bayer’s stock and Monsanto’s legacy cases are likely to stabilize, but the ruling may fuel further debate over regulatory oversight of glyphosate. Watch for potential legislative responses, including calls for stricter EPA reviews or state-level bans on glyphosate use, as well as possible appeals from plaintiffs’ groups.